Insys Therapeutics to Report Second Quarter 2017 Results on August 3, 2017
July 20 2017 - 6:50AM
Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “Company”) today
announced that the Company will release its second quarter 2017
financial results on Thursday, August 3, 2017, before the U.S.
financial markets open.
Following the release of the financial results, Saeed Motahari,
President and Chief Executive Officer, and Darryl S. Baker, Chief
Financial Officer, will host a conference call at 8:30 a.m. Eastern
Daylight Time.
Interested parties may participate in the conference call by
dialing (844) 263-8304 (U.S.) or (213) 358-0958 (International),
5-10 minutes prior to the start of the call. A replay will be
available shortly after the completion of the call for one week by
dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International) and
entering conference call ID number 55335437.
A live audio webcast and archive of the call will also be
available at www.insysrx.com.
About Insys Insys Therapeutics is a specialty
pharmaceutical company that develops and commercializes innovative
drugs and novel drug delivery systems of therapeutic molecules that
improve the quality of life of patients. Using proprietary
sublingual spray technology and capabilities to develop
pharmaceutical cannabinoids, INSYS is developing a pipeline of
products intending to address unmet medical needs and the clinical
shortcomings of existing commercial products. INSYS currently
markets one product, SUBSYS® (fentanyl sublingual spray) and has
received approval for the marketing of SYNDROS™ (dronabinol oral
solution), a proprietary, orally administered liquid formulation of
dronabinol. INSYS is committed to developing medications for
potentially treating addiction to opioids, opioid overdose,
epilepsy, and other disease areas with a significant unmet
need.
SUBSYS® and SYNDROS™ are trademarks of Insys Development
Company, Inc., a subsidiary of Insys Therapeutics, Inc.
Contact:
Lisa M. Wilson
T: 212-452-2793
E: INSYS@insysrx.com
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Apr 2023 to Apr 2024